Crossmark

The deubiquitinating enzyme regulatory network in malignant progression of breast cancer encompasses mechanisms of action, clinical significance and emerging therapeutic targets

Crossref DOI link: https://doi.org/10.1007/s12672-026-05894-1

Published Online: 2026-09-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Xiaoyu

Yang, Dunya

Lin, Xiangwu

Yang, Zhirong

Lin, Yun

Yao, Juan

Chen, Lingdan

Chen, Xi

Liu, Shiyu

Chen, Qunxiang https://orcid.org/0009-0007-7888-8504
Funding

Funding for this research was provided by:

Fujian Provincial Natural Science Foundation of China (2023J011356)

Fujian Provincial Natural Science Foundation of China (2026J0011419)

Joint Logistic Medical Quality Specialty (LQYZ-ZL)
License Information

Text and Data Mining valid from 2026-09-10

Accepted Manuscript valid from 2026-09-10
More Information

Article History

Received: 1 May 2026

Accepted: 2 September 2026

First Online: 10 September 2026

Declarations

Ethics approval and consent to participate: Not applicable.

Consent for publication: Not applicable.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below